CTKB 8-K 2026-09-29
Cytek Biosciences, Inc. (CTKB) 8-K dated 2026-09-29 — accession 0001193125-26-407330.
Cytek Biosciences, Inc. (CTKB) is a medical devices company listed on US.
Cytek Biosciences, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407330.
This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CTKB revenue for 2025-12-31 was $201.5M. Net income was -$66.5M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CTKB currently screens at market cap $421.8M.
Not investment advice. The CTKB SEC hub lists recent forms. The stock page is the research view.